NO921876L - Enzymatisk spaltning av endo-bicyklo(2,2.1)heptan-2-ol ogavledede farmasoeytisk midler - Google Patents

Enzymatisk spaltning av endo-bicyklo(2,2.1)heptan-2-ol ogavledede farmasoeytisk midler

Info

Publication number
NO921876L
NO921876L NO92921876A NO921876A NO921876L NO 921876 L NO921876 L NO 921876L NO 92921876 A NO92921876 A NO 92921876A NO 921876 A NO921876 A NO 921876A NO 921876 L NO921876 L NO 921876L
Authority
NO
Norway
Prior art keywords
endo
pharmasoeytic
heptan
bicyclo
derivative
Prior art date
Application number
NO92921876A
Other languages
English (en)
Other versions
NO921876D0 (no
NO304838B1 (no
Inventor
Nicholas A Saccomano
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO921876D0 publication Critical patent/NO921876D0/no
Publication of NO921876L publication Critical patent/NO921876L/no
Publication of NO304838B1 publication Critical patent/NO304838B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO921876A 1989-11-13 1992-05-12 FremgangsmÕte for fremstilling av endo-bicyklo[2,2.1]heptan-2-oler og farmas°ytisk aktive derivater derav NO304838B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005228 WO1991007501A1 (en) 1989-11-13 1989-11-13 Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents

Publications (3)

Publication Number Publication Date
NO921876D0 NO921876D0 (no) 1992-05-12
NO921876L true NO921876L (no) 1992-07-10
NO304838B1 NO304838B1 (no) 1999-02-22

Family

ID=22215375

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921876A NO304838B1 (no) 1989-11-13 1992-05-12 FremgangsmÕte for fremstilling av endo-bicyklo[2,2.1]heptan-2-oler og farmas°ytisk aktive derivater derav

Country Status (27)

Country Link
EP (2) EP0428302B1 (no)
JP (1) JPH06104661B2 (no)
KR (1) KR930004654B1 (no)
CN (1) CN1040423C (no)
AT (1) ATE158577T1 (no)
AU (3) AU633157B2 (no)
CA (1) CA2029705C (no)
CZ (2) CZ280006B6 (no)
DE (1) DE69031487T2 (no)
DK (1) DK0428302T3 (no)
EG (1) EG19860A (no)
ES (1) ES2107420T3 (no)
FI (1) FI105106B (no)
GR (1) GR3025196T3 (no)
HU (2) HU220962B1 (no)
IE (2) IE980174A1 (no)
IL (5) IL110564A (no)
MY (1) MY104517A (no)
NO (1) NO304838B1 (no)
NZ (1) NZ236037A (no)
PH (1) PH30255A (no)
PL (4) PL165132B1 (no)
PT (1) PT95855B (no)
RU (1) RU2104306C1 (no)
WO (1) WO1991007501A1 (no)
YU (1) YU48413B (no)
ZA (1) ZA909044B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104306C1 (ru) * 1989-11-13 1998-02-10 Пфайзер Инк. Способ получения оптически активного (2s)- или (2r)-эндо-бицикло[2.2.1]гептан-2-ола, способ получения 5-(3-[(2r)-экзо-бицикло[2.2.1]гепт-2-илокси]-4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-она, оптически активный 5-(3-[экзо-бицикло[2.2.1]гепт-2-илокси]4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-он, оптически активные промежуточные соединения и способ их получения
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
DE69226942T2 (de) * 1991-12-06 1999-05-20 Shionogi Seiyaku K.K., Osaka Verfahren zur herstellung von optisch aktivem norborneol
CA2150812C (en) * 1992-12-02 2002-12-24 Allen J. Duplantier Catechol diethers as selective pde iv inhibitors
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
JP3431204B2 (ja) * 1993-04-22 2003-07-28 塩野義製薬株式会社 ノルボルナン型エステル・ヒドロラーゼ
CN1041436C (zh) * 1993-05-07 1998-12-30 佛山市制药一厂 一种稳定冯了性风湿跌打药酒的方法
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
JPH1142095A (ja) * 1997-07-25 1999-02-16 Chisso Corp 新規なオキソジシクロペンタジエンの製造方法
KR100479019B1 (ko) * 1998-05-22 2005-08-29 씨제이 주식회사 캐테콜히드라존유도체,이의제조방법및그를함유한약제학적조성물
MXPA02001830A (es) 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
KR20040017246A (ko) 2001-06-29 2004-02-26 니켄 가가쿠 가부시키가이샤 사이클로알케논 유도체
ES2194588B1 (es) * 2001-07-13 2004-10-16 Astur Pharma S.A. Precursores opticamente puros de paroxetina.
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
CN105979959B (zh) 2013-08-09 2021-11-30 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261995A (en) * 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives
US4732853A (en) * 1984-11-21 1988-03-22 President And Fellows Of Harvard College Method of making chiral epoxy alcohols
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
RU2104306C1 (ru) * 1989-11-13 1998-02-10 Пфайзер Инк. Способ получения оптически активного (2s)- или (2r)-эндо-бицикло[2.2.1]гептан-2-ола, способ получения 5-(3-[(2r)-экзо-бицикло[2.2.1]гепт-2-илокси]-4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-она, оптически активный 5-(3-[экзо-бицикло[2.2.1]гепт-2-илокси]4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-он, оптически активные промежуточные соединения и способ их получения

Also Published As

Publication number Publication date
FI922142A (fi) 1992-05-12
CZ124092A3 (en) 1995-04-12
PL292069A1 (en) 1992-04-21
PT95855A (pt) 1991-09-13
FI105106B (fi) 2000-06-15
AU6653590A (en) 1991-05-16
IL110568A (en) 1995-10-31
IL96261A0 (en) 1991-08-16
PL292070A1 (en) 1992-04-21
KR930004654B1 (ko) 1993-06-02
CZ280006B6 (cs) 1995-09-13
HUT64604A (en) 1994-01-28
ES2107420T3 (es) 1997-12-01
DE69031487D1 (de) 1997-10-30
FI922142A0 (fi) 1992-05-12
AU645449B2 (en) 1994-01-13
CA2029705C (en) 1998-11-24
JPH03173871A (ja) 1991-07-29
JPH06104661B2 (ja) 1994-12-21
NO921876D0 (no) 1992-05-12
HU9802988D0 (en) 1999-11-29
PL164202B1 (pl) 1994-06-30
PL164176B1 (pl) 1994-06-30
PL164457B1 (pl) 1994-07-29
AU3292093A (en) 1993-04-22
DK0428302T3 (da) 1997-10-13
WO1991007501A1 (en) 1991-05-30
AU3197993A (en) 1993-04-22
IL110568A0 (en) 1994-11-11
PL165132B1 (pl) 1994-11-30
AU633157B2 (en) 1993-01-21
HU215441B (hu) 1999-04-28
DE69031487T2 (de) 1998-02-05
IE904059A1 (en) 1991-05-22
IE980174A1 (en) 2000-02-23
PL287727A1 (en) 1992-02-24
NZ236037A (en) 1992-08-26
CN1040423C (zh) 1998-10-28
ATE158577T1 (de) 1997-10-15
HU220962B1 (hu) 2002-07-29
YU48413B (sh) 1998-07-10
EP0428302A3 (en) 1992-05-13
KR910009622A (ko) 1991-06-28
IL96261A (en) 1996-12-05
IL110564A (en) 1998-03-10
EP0801135A1 (en) 1997-10-15
YU214290A (sh) 1992-12-21
IL110564A0 (en) 1994-11-11
CZ560990A3 (en) 1995-04-12
GR3025196T3 (en) 1998-02-27
NO304838B1 (no) 1999-02-22
CA2029705A1 (en) 1991-05-14
MY104517A (en) 1994-04-30
EP0428302A2 (en) 1991-05-22
EG19860A (en) 1996-03-31
PH30255A (en) 1997-02-05
CN1051905A (zh) 1991-06-05
RU2104306C1 (ru) 1998-02-10
PT95855B (pt) 1998-01-30
EP0428302B1 (en) 1997-09-24
ZA909044B (en) 1992-06-24
CZ280011B6 (cs) 1995-09-13

Similar Documents

Publication Publication Date Title
NO921876D0 (no) Enzymatisk spaltning av endo-bicyklo(2,2.1)heptan-2-ol ogavledede farmasoeytisk midler
DK0832245T4 (da) Rekombinant hexoseoxidase, en fremgangsmåde til at fremstille samme samt anvendelse af et sådan enzym
AR244918A1 (es) Un amplificador optico del tipo de fibra activa
AU6881791A (en) Mammalian pancreatic cholesterol esterase
DK0739985T3 (da) Fremgangsmåde til interesterifikation af phospholipider
UA29459C2 (uk) Спосіб виготовлення оптичних структур та пристрій для здійснення операції плавлення
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DK0407212T3 (da) Enantioselektiv syntese af antifolater
DK0409521T3 (da) Forbedret enzymatisk oxidation af Ceph C til glutaryl-7-aminocephalosporansyre
DK0446826T3 (da) Fremgangsmåde til enzymatisk fremstilling af optisk aktive cyanhydriner
DK392287D0 (da) Fremgangsmaade til fremstilling af penem-allyl-estere samt mellemprodukt til brug ved fremgangsmaaden
EP0728708A3 (en) Method of manufacturing a stable polarized optical fiber
DK151288A (da) Fremgangsmaade og paasaetningsmekanisme til paasaetning af baerekartoner paa grupper af genstande
ES2054916T3 (es) Gen y producto de gen para la obtencion de compuestos de beta-lactama.
BR9406442A (pt) Processo para a expressao de um antígeno de enzima
FI883135A0 (fi) Homocyklostatin och cyklostatin innehaollande polypeptider som antihypertensiva medel.